Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 2856 for cancer

Edit search filters
  1. Colorectal Cancer Screening/Microbiome Collection

    Jacksonville, FL

  2. A Study Of Imlunestrant Versus Standard Endocrine Therapy In Participants With Early Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Phase 1a/​1b Study Of Aplitabart (IGM-8444) Alone Or In Combination In Participants With Relapsed, Refractory, Or Newly Diagnosed Cancers

    Scottsdale/Phoenix, AZ

  4. Ulixertinib In People With Histiocytic Neoplasms

    Rochester, MN

  5. A First-in-Human Study Of MEN2312 In Adults With Advanced Breast Cancer

    Rochester, MN

  6. A Clinical Study To Investigate The Efficacy And Safety Of An Investigational Combination Therapy With BNT324 And BNT327 In Patients With Advanced Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Study Of Lunresertib Alone Or In Combination With RP-3500 Or Debio 0123 In Patients With Advanced Solid Tumors

    Jacksonville, FL, Rochester, MN

  8. HTN Management And Cardiovascular Adverse Event Prevention In B-Cell Malignancies Undergoing BTKi

    Rochester, MN

  9. Study Of EO-3021 In Adult Patients With Solid Tumors Likely To Express CLDN18.2

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Investigate ALE.P02 As Monotherapy In Adult Patients With Selected CLDN1+ Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer